financetom
Business
financetom
/
Business
/
S&T Bancorp Q3 net income up on margin expansion
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
S&T Bancorp Q3 net income up on margin expansion
Oct 23, 2025 4:52 AM

Overview

* S&T Bancorp ( STBA ) Q3 net income rises to $35.0 mln, EPS increases to $0.91

* Net interest income grows 3% in Q3, reflecting margin expansion

* Nonperforming assets increase to $49.6 mln, net charge-offs rise

Outlook

* Company did not provide specific future guidance

Result Drivers

* NET INTEREST INCOME - Net interest income increased by $2.6 mln, or 3%, driven by a 5 basis point expansion in net interest margin

* LOAN GROWTH - Total portfolio loans increased by $46.6 mln, driven by growth in residential mortgage and home equity loans

* EXPENSE MANAGEMENT - Noninterest expenses decreased by $1.7 mln due to lower salaries and professional services costs

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 EPS $0.91

Q3 Net $34.96

Income mln

Q3 Net $89.24

Interest mln

Income

Q3 $2.79

Credit mln

Loss

Provisio

n

Analyst Coverage

* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy", 6 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the banks peer group is "buy."

* Wall Street's median 12-month price target for S&T Bancorp Inc ( STBA ) is $41.00, about 12.7% above its October 21 closing price of $35.81

* The stock recently traded at 10 times the next 12-month earnings vs. a P/E of 11 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Relativity Acquisition Corp. SPAC and Instinct Bio Technical Co. Announce Effectiveness of Registration Statement
Relativity Acquisition Corp. SPAC and Instinct Bio Technical Co. Announce Effectiveness of Registration Statement
Nov 12, 2025
Las Vegas, NV, Tokyo, Japan, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Special purpose acquisition company, Relativity Acquisition Corp. (“Relativity”), and Instinct Bio Technical Company Inc. (“Instinct Bio”) today announced that on November 12, 2025, the registration statement on Form F-4, as amended (the “Registration Statement”), in connection with Relativity’s previously announced proposed business combination (the “Business Combination”) with Instinct Brothers Co., Ltd. (“Instinct Brothers”), a...
Rush Street Interactive Insider Sold Shares Worth $3,388,907, According to a Recent SEC Filing
Rush Street Interactive Insider Sold Shares Worth $3,388,907, According to a Recent SEC Filing
Nov 12, 2025
06:01 PM EST, 11/12/2025 (MT Newswires) -- Richard Todd Schwartz, Director, Chief Executive Officer, on November 10, 2025, sold 193,905 shares in Rush Street Interactive ( RSI ) for $3,388,907. Following the Form 4 filing with the SEC, Schwartz has control over a total of 380,242 Class A common shares of the company, with 380,242 shares held directly. SEC Filing:...
KinderCare Learning Fiscal Q3 Adjusted Earnings, Revenue Rise; 2025 Outlook Lowered
KinderCare Learning Fiscal Q3 Adjusted Earnings, Revenue Rise; 2025 Outlook Lowered
Nov 12, 2025
06:07 PM EST, 11/12/2025 (MT Newswires) -- KinderCare Learning ( KLC ) reported fiscal Q3 adjusted earnings late Wednesday of $0.13 per diluted share, up from $0.05 a year earlier. Revenue in the three months ended Sept. 27 rose to $676.8 million from $671.5 million a year earlier. Analysts surveyed by FactSet expected $682.6 million. The company expects full-year adjusted...
Medexus Pharma Q2 revenue misses estimates
Medexus Pharma Q2 revenue misses estimates
Nov 12, 2025
Nov 12 (Reuters) - Overview * Medexus fiscal Q2 2026 revenue of $24.7 mln missed analyst expectations * Company's adjusted EBITDA decreased due to GRAFAPEX investments and Rupall competition * Gross margin improved to 55.7% from 53.7% year-over-year Outlook * Medexus expects GRAFAPEX to be accretive to cash flows by fiscal Q3 2026 * Company anticipates GRAFAPEX revenue to exceed...
Copyright 2023-2026 - www.financetom.com All Rights Reserved